WELL Health Announces Receipt of MCTO
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has received a Management Cease Trade Order (MCTO) from the British Columbia Securities Commission following a delay in filing its Annual Filings for the year ended December 31, 2024. The MCTO restricts the CEO and CFO from trading company securities until the required documents are filed.
The Annual Filings include the company's annual information form, audited annual financial statements, and management's discussion and analysis. During this period, the company has committed not to issue or acquire securities from insiders or employees. The MCTO does not affect non-insider shareholders' ability to trade.
The company will provide bi-weekly default status reports and announce completion once the Annual Filings are submitted to SEDAR+.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) ha ricevuto un'Ordine di Sospensione della Negoziazione da parte della British Columbia Securities Commission a seguito di un ritardo nella presentazione dei documenti annuali per l'anno conclusosi il 31 dicembre 2024. L'Ordine di Sospensione limita il CEO e il CFO dal negoziare titoli della società fino a quando i documenti richiesti non saranno presentati.
I documenti annuali includono il modulo informativo annuale della società, i bilanci annuali auditati e la discussione e analisi della direzione. Durante questo periodo, la società si è impegnata a non emettere né acquisire titoli da insider o dipendenti. L'Ordine di Sospensione non influisce sulla capacità degli azionisti non insider di negoziare.
La società fornirà rapporti sullo stato di inadempienza ogni due settimane e annuncerà il completamento una volta che i documenti annuali saranno presentati a SEDAR+.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) ha recibido una Orden de Suspensión de Negociación de la British Columbia Securities Commission tras un retraso en la presentación de sus Documentos Anuales para el año que finalizó el 31 de diciembre de 2024. La Orden de Suspensión restringe al CEO y al CFO de negociar valores de la empresa hasta que se presenten los documentos requeridos.
Los Documentos Anuales incluyen el formulario de información anual de la empresa, los estados financieros anuales auditados y la discusión y análisis de la dirección. Durante este período, la empresa se ha comprometido a no emitir ni adquirir valores de personas internas o empleados. La Orden de Suspensión no afecta la capacidad de los accionistas no internos para negociar.
La empresa proporcionará informes sobre el estado de incumplimiento cada dos semanas y anunciará la finalización una vez que los Documentos Anuales se presenten a SEDAR+.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF)는 2024년 12월 31일 종료 연도의 연간 보고서 제출 지연으로 인해 브리티시컬럼비아 증권 위원회로부터 거래 중단 명령(MCTO)을 받았습니다. MCTO는 CEO와 CFO가 필요한 문서가 제출될 때까지 회사 증권 거래를 제한합니다.
연간 보고서에는 회사의 연간 정보 양식, 감사된 연간 재무제표 및 경영진의 논의 및 분석이 포함됩니다. 이 기간 동안 회사는 내부자 또는 직원으로부터 증권을 발행하거나 인수하지 않겠다고 약속했습니다. MCTO는 비내부 주주가 거래하는 능력에는 영향을 미치지 않습니다.
회사는 2주마다 기본 상태 보고서를 제공하고 연간 보고서가 SEDAR+에 제출되면 완료를 발표할 것입니다.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) a reçu un Ordre de Suspension de Négociation (MCTO) de la part de la British Columbia Securities Commission suite à un retard dans le dépôt de ses Déclarations Annuelles pour l'exercice clos le 31 décembre 2024. Le MCTO interdit au PDG et au directeur financier de négocier des titres de la société jusqu'à ce que les documents requis soient déposés.
Les Déclarations Annuelles comprennent le formulaire d'information annuel de la société, les états financiers annuels audités et la discussion et analyse de la direction. Pendant cette période, la société s'est engagée à ne pas émettre ni acquérir de titres d'insiders ou d'employés. Le MCTO n'affecte pas la capacité des actionnaires non-insiders à négocier.
La société fournira des rapports bi-hebdomadaires sur l'état de la situation et annoncera l'achèvement une fois que les Déclarations Annuelles auront été soumises à SEDAR+.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) hat von der British Columbia Securities Commission eine Management Cease Trade Order (MCTO) erhalten, nachdem die Einreichung der Jahresberichte für das am 31. Dezember 2024 endende Jahr verzögert wurde. Die MCTO schränkt den CEO und CFO ein, Unternehmenswerte zu handeln, bis die erforderlichen Dokumente eingereicht sind.
Die Jahresberichte umfassen das jährliche Informationsformular des Unternehmens, die geprüften Jahresfinanzberichte sowie die Diskussion und Analyse des Managements. Während dieses Zeitraums hat sich das Unternehmen verpflichtet, keine Wertpapiere von Insidern oder Mitarbeitern auszugeben oder zu erwerben. Die MCTO hat keinen Einfluss auf die Handelsmöglichkeiten von nicht-internen Aktionären.
Das Unternehmen wird alle zwei Wochen Berichte über den Status des Verstoßes bereitstellen und die Fertigstellung bekannt geben, sobald die Jahresberichte bei SEDAR+ eingereicht sind.
- Regular shareholders maintain ability to trade shares
- Company committed to bi-weekly updates through status reports
- Delay in filing required annual financial documents indicates potential internal control or reporting issues
- Trading restrictions imposed on company executives through MCTO
- Company unable to issue new securities to insiders during MCTO period
The MCTO does not affect the ability of any shareholders who are not insiders of the Company to trade their securities of the Company.
The Company will issue a news release announcing completion of filing of the Annual Filings at such time as they are completed and filed. Until the Company files the Annual Filings, it will comply with the alternative information guidelines set out in under National Policy 12-203 – Management Cease Trade Orders, including issuing bi-weekly default status reports by way of news releases, which will be filed on SEDAR+.
The delay in the Annual Filings arises from the matters previously disclosed in WELL's news release dated March 28, 2025. WELL continues to work toward completing the filings as soon as practicable.
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL Health Technologies Corp.
WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 41,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 200 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more about the Company, please visit: www.well.company.
View original content to download multimedia:https://www.prnewswire.com/news-releases/well-health-announces-receipt-of-mcto-302417729.html
SOURCE WELL Health Technologies Corp.
FAQ
What does the MCTO mean for WHTCF shareholders?
What documents are delayed in WHTCF's Annual Filings for 2024?
How will WHTCF keep investors updated during the MCTO period?
What trading restrictions does the MCTO impose on WHTCF?
